Tag: personalized medicine
-
Targeted mRNA Vaccines for Cancer: Training the Immune System to Destroy Tumors
What Are Targeted mRNA Vaccines for Cancer? Targeted messenger RNA (mRNA) vaccines are a cutting-edge form of cancer immunotherapy. Unlike traditional treatments that attack tumors directly with chemotherapy or radiation, these vaccines aim to train the patient’s own immune system to recognize and destroy cancer cells. By delivering genetic instructions to cells, mRNA vaccines prompt…
-
How Modified Robotic Prosthetics Could Ease Hip and Back Problems for Amputees
Reimagining Prosthetic Design for Whole-Body Benefits Robotic prosthetics have evolved from simple, body-anchored extensions to sophisticated systems that actively collaborate with the wearer. Recent advances combine two key processes into a single personalized algorithm: tailoring the prosthetic’s movement to the user and guiding the body to adopt a more natural, efficient gait. The result is…
-
Immunotherapy Advances in SCLC: Promise, Limitations, and the Biomarker Gap
Immunotherapy Advances in Small Cell Lung Cancer (SCLC): A Quiet but Persistent Shift Small cell lung cancer has long challenged clinicians with its aggressive biology and historically limited treatment options. In recent years, immunotherapy has emerged as a meaningful, if nuanced, addition to the standard of care. The story is not a single triumph but…
-
Oncomarkers Awareness Day: Advancing Precision Oncology Through Biomarker Science
Introduction: A Global Day for Biomarker Science Oncomarkers Awareness Day, first observed on November 13, 2025, marks a milestone in the cancer care landscape. This international observance highlights how biomarkers—the measurable indicators of biological processes—are shaping precision oncology. By providing richer diagnostic insights, guiding therapy choices, and monitoring treatment response, biomarkers are helping clinicians tailor…
-
Ireland Bleeding Disorders Research Changing Global Practice
What the research is about My work centers on inherited bleeding disorders, a spectrum that includes well-known conditions like haemophilia and less familiar ones such as von Willebrand disease. At its core, these disorders involve a disruption in the body’s ability to form clots, which can lead to excessive or unusual bleeding. While each condition…
-
Age Impacts Therapy Outcomes in Metastatic Prostate Cancer
New evidence ties age to outcomes in metastatic prostate cancer A new study published in the October 28, 2025 edition of the New England Journal of Medicine adds an important dimension to how doctors tailor systemic therapy for metastatic prostate cancer. While factors such as tumor biology, disease burden, and prior treatments have long guided…
-
Age Impacts Systemic Therapy in Metastatic Prostate Cancer
New evidence links age to systemic therapy outcomes in metastatic prostate cancer When oncologists assemble a treatment plan for metastatic prostate cancer, they weigh many factors—from tumor genetics to patient comorbidities. A provocative addition to this list is chronological age. A study published in the October 28, 2025 edition of the New England Journal of…
-
Canada’s Largest Cancer Centre to Offer Genomic Testing to All Patients in Five-Year Study
Groundbreaking five-year study to offer genomic testing to all patients In a major advance for personalized cancer care, Canada’s Princess Margaret Cancer Centre in Toronto announced a comprehensive plan to offer genomic testing to every patient treated at the facility over the next five years. The initiative aims to uncover hereditary health risks hidden in…
-
Ontario to Screen Up to 100,000 for Hereditary Cancer Risks and Familial Hypercholesterolemia
What’s happening In a bold, multi-year initiative, Princess Margaret Cancer Centre plans to screen up to 100,000 Ontarians over the next five years for genetic conditions that raise the risk of hereditary cancers and a condition linked to high cholesterol and heart disease. The project aims to shift care from reactive treatment to proactive prevention…
-
Canada’s Princess Margaret to Offer Genomic Testing to All Cancer Patients in Five-Year Joint U.S. Study
Overview: A New Era in Cancer Care Canada’s largest cancer centre is launching a five-year program to offer genomic testing to every patient treated at the Princess Margaret Cancer Centre in Toronto. The initiative, developed in collaboration with major U.S. hospitals, aims to identify hereditary health risks hidden in patients’ DNA and to integrate these…